CAR-T Therapy Slows Multiple Myeloma in Patients Who Have Stopped Responding to Other Treatments
In a Phase 3 study, MCW Cancer Center investigators found that patients with Multiple Myeloma who were treated with a unique CAR-T therapy experienced significantly positive results, findings which could lead to a new standard of care for the treatment of this disease.
Combination of Chemotherapy and CAR-T Therapy Helps Leukemia Patients Achieve Remission
MCW Cancer Center investigators discovered that chemotherapy coupled with CAR-T infusion helped patients with acute lymphocytic leukemia achieve another remission, opening the door to promising new therapies.
“Rockstar” Treatment for Patients with Chronic Graft-Versus-Host Disease
MCW Cancer Center scientists conducted a pivotal trial leading to the expedited FDA approval of REZUROCK, a ground-breaking new therapy that works by rebalancing a patient’s immune system.